Mark Strobeck
CIK 1599219 · President and CEO · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.04M
Companies
4
Total Filings
43
Lifetime Open-Market Net
-$989.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | President and CEO | 323,493 | $0.62 | $202.1K | -$39.5K | 14 | 2026-04-17 |
| WINT | Director | 2,300 | $0.01 | $33 | $0 | 1 | 2023-08-25 |
| ASRT | EVP & Chief Operating Officer | 248,599 | $23.48 | $5.84M | $0 | 1 | 2020-05-22 |
| Zyla Life Sciences (EGLT) Delisted | Chief Operating Officer | 317,080 | — | — | -$949.5K | 21 | 2018-06-15 |
Recent Filings · Page 3 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-28 | — | Grant (A) | +120,000 | $0 | |
| 2019-02-04 | — | Disp (D) | −317,080 | $0 | |
| 2018-06-15 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | +225,000 | $0 | EDGAR |
| 2018-03-08 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
| 2017-10-03 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −8,700 | -$11.2K | EDGAR |
| 2017-07-05 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −8,700 | -$20.8K | EDGAR |
| 2017-06-12 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-31 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −8,700 | -$44.5K | EDGAR |
| 2017-01-04 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −8,700 | -$67.9K | EDGAR |
| 2016-12-08 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.